THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer THEMIS MEDICARE LTD. - 530199 - Shareholding for the Period Ended December 31, 2019
Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here Themis Medicare Ltd - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record. Themis Medicare Ltd - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from shareholder as per enclosed letter. This may be taken as compliance under the Listing Regulations THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2nd April, 2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1st January, 2020 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 31st December, 2019 by the Board of Directors of the Company. THEMIS MEDICARE LTD. - 530199 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended September 30, 2019. THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed copies of advertisement published in newspaper(s) viz. the 'The Times of India' (English) and 'The Economic Times' (Gujarati) newspaper dated 15th November, 2019 for the Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2019. THEMIS MEDICARE LTD. - 530199 - Grant Of Options Under THEMIS MEDICARE ESOS 2012
The Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held today i.e. on November 14, 2019, has granted 20,000 Stock Options exercisable into an equal number of Equity Shares of Rs. 10/- each under Themis Medicare Employee Stock Option Scheme 2012 (''Themis Medicare ESOS 2012'') to an eligible employee, at a price of Rs. 303/- per option, being the closing price on November 13, 2019, the day preceding to the date of the Meeting, on National Stock Exchange (NSE) where the traded volume was high. These options will vest in the favour of the option grantee over a period of 3 years from the date of grant as per ''Themis Medicare ESOS 2012''. This is for your information and record. Themis Medicare Ltd - 530199 - Financial Results For The Quarter And Half Year Ended 30Th September, 2019
The Board of Directors at its meeting held today, considered and approved the following matters 1. Approved the Unaudited Standalone and Consolidated financial results for the Quarter and Half Year ended 30th September, 2019. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2019 is enclosed herewith. 2. Re-constituted the Nomination and Remuneration Committee of the Board of Directors of the Company pursuant to Section 178 of the Companies Act and Regulation 19 of the SEBI (LODR) Regulations, 2015. The revised composition of the Nomination and Remuneration Committee is as under: Mr. Vijay Agarwal Chairman of the Committee Mr. Humayun Dhanrajgir Member of the Committee Mr. H. Subramaniam Member of the Committee Mr. Rajneesh Anand Member of the Committee This may be taken as compliance under the Listing Regulations. Themis Medicare Ltd - 530199 - Outcome Of Board Meeting Held On November 14, 2019
The Board of Directors at its meeting held today, considered and approved the following matters 1. Approved the Unaudited Standalone and Consolidated financial results for the Quarter and Half Year ended 30th September, 2019. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2019 is enclosed herewith. 2. Re-constituted the Nomination and Remuneration Committee of the Board of Directors of the Company pursuant to Section 178 of the Companies Act and Regulation 19 of the SEBI (LODR) Regulations, 2015. The revised composition of the Nomination and Remuneration Committee is as under: Mr. Vijay Agarwal Chairman of the Committee Mr. Humayun Dhanrajgir Member of the Committee Mr. H. Subramaniam Member of the Committee Mr. Rajneesh Anand Member of the Committee This may be taken as compliance under the Listing Regulations.